Pesquisar
Smith & Nephew PLC
SNNAdicionar à lista de desejos
27.500USD
-0.190-0.69%
Fechamento 09-22 16:00（ET）
11.51BValor de mercado
24.46P/L TTM
Sobre o Smith & Nephew PLC Empresa
Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing, and selling medical devices and services. It is focused on the repair, regeneration, and replacement of soft and hard tissue. The Company's segments include Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip, knee and shoulder implants used to replace diseased, damaged or worn joints, robotics-assisted enabling technologies that empower surgeons, and trauma products used to stabilise severe fractures and correct bone deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue. Its Advanced Wound Management portfolio provides a comprehensive set of products to meet broad and complex clinical needs, and to help healthcare professionals reduce the human and economic consequences of wounds.
Smith & Nephew PLC Perfil
Código da empresaSNN
Nome da EmpresaSmith & Nephew PLC
Data de listagemSep 18, 2087
CEONath (Deepak S)
Número de funcionários17349
Tipo de títulosDepository Receipt
Fim do ano fiscalSep 18
EndereçoBuilding 5
CidadeWATFORD
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited Kingdom
Código postalWD18 8YE
Telefone4401923477100
Sitehttps://www.smith-nephew.com/
Código da empresaSNN
Data de listagemSep 18, 2087
CEONath (Deepak S)
Executivos da empresa Smith & Nephew PLC
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
18.46K
--
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.84K
+15.27%
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.84K
+15.27%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.83K
+15.32%
Mr. Paul Connolly
Mr. Paul Connolly
President - Global Operations
President - Global Operations
2.83K
+15.32%
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Mr. David King
Mr. David King
Non-Executive Independent Director
Non-Executive Independent Director
2.80K
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
18.46K
--
Dr. Ajay Dhankhar, Ph.D.
Dr. Ajay Dhankhar, Ph.D.
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
Chief Strategy & Corporate Development Officer, Corporate Branding and External Communications
18.46K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Dr. Garheng Kong, M.D., Ph.D.
Dr. Garheng Kong, M.D., Ph.D.
Independent Non-Executive Director
Independent Non-Executive Director
3.00K
--
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.84K
+15.27%
Mr. Deepak S. Nath
Mr. Deepak S. Nath
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.84K
+15.27%
Perguntas frequentes
Quem são os cinco principais acionistas de Smith & Nephew PLC?
Os cinco principais acionistas de Smith & Nephew PLC são: Dr. Ajay Dhankhar, Ph.D.
Quantas instituições possuem ações da Smith & Nephew PLC (SNN)?
Em 2026Q1, 471 instituições possuíam ações da Smith & Nephew PLC, com valor de mercado aproximado de 30.95M, representando 7.25% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -11491314.00.
Qual é a maior fonte de receita da Smith & Nephew PLC?
Em 2026Q1, o segmento de negócios Advanced Wound Care gerou a maior receita para Smith & Nephew PLC, totalizando 300.00M e representando 18.80% da receita total.